Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database
暂无分享,去创建一个
Cahn | Molina | L. J. | L. | N. | Michallet | Milpied | S. | Guilhot | F. | Rio | L. J | Gaulard | B. | Laporte | Kuentz | Ifrah | P. | Dhedin | Giraudier | Esperou | M. | H. | L. Orte | N. A. | Gaula | Michall | Milpie | Kuent
[1] J. Armitage,et al. Allogeneic bone marrow transplantation for low-grade lymphoma. , 1998, Blood.
[2] M. Hessner,et al. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin’s lymphoma: clinical and molecular follow-up , 1998, Bone Marrow Transplantation.
[3] A. Nagler,et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.
[4] T. de Witte,et al. Allogeneic bone marrow transplantation with T‐cell‐depleted marrow grafts for patients with poor‐risk relapsed low‐grade non‐Hodgkin's lymphoma , 1998, British journal of haematology.
[5] L. Verdonck,et al. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. , 1997, Blood.
[6] R. Larson,et al. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma , 1997, Bone Marrow Transplantation.
[7] K. Cleary,et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect , 1997, Bone Marrow Transplantation.
[8] A. Pileri,et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. , 1997, The New England journal of medicine.
[9] P. Gaulard,et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Kantarjian,et al. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology. , 1996, The American journal of medicine.
[11] D. Deakin,et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] P. Moreau,et al. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma. , 1996, Bone marrow transplantation.
[13] A. Hagenbeek,et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.
[14] B. Andersson,et al. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S C Strother,et al. Commentary and Opinion: I. Principal Component Analysis, Variance Partitioning, and “Functional Connectivity” , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] L. Madero,et al. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. , 1995, Bone marrow transplantation.
[17] M. Lill,et al. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. , 1995, Bone marrow transplantation.
[18] B. Coiffier,et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] D. Arthur,et al. L3 acute lymphoblastic leukemia. Comparison with small noncleaved cell lymphoma involving the bone marrow. , 1994, American journal of clinical pathology.
[20] J. Spinelli,et al. Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma. , 1993, Bone marrow transplantation.
[21] S. Horning. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. , 1993, Seminars in oncology.
[22] T M Grogan,et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[23] L. Gordon,et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. , 1992, The New England journal of medicine.
[24] R. Chopra,et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] C. Lawton,et al. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] S. Piantadosi,et al. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. , 1991, Blood.
[27] X. Troussard,et al. Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] D. Blaise,et al. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission , 1989, British journal of haematology.
[29] B. Coiffier,et al. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] H. Deeg,et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] J. Armitage,et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.
[32] J. Fay,et al. High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] W. Woods,et al. Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. A pilot study. , 1983, The American journal of medicine.
[34] B. Nathwani,et al. Lymphoblastic lymphoma: A clinicopathologic study of 95 patients , 1981, Cancer.
[35] J. Dausset,et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma , 1981 .
[36] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[37] D. Neuberg,et al. T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin ’ s lymphoma , 1998 .
[38] E. Abella,et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. , 1994, Blood.
[39] D. Weisenburger,et al. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. , 1989, Bone marrow transplantation.
[40] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[41] J. Dausset,et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. , 1981, Blood.